From the figures alone we cannot be encouraged in the hope that the large psychiatric hospitals will readily be emptied of their long-stay populations, by whatever means. In Salford, at least, it is a population ever longer-staying, not by any means al old, increasingly difficult to discharge, and dying only slowly. And we replenish it year by year with new patients. We must examine the people concerned to discover what the "need" really is and to make rational provision, but the hospital and social services must work closely together to achieve this.
Placental Lactogen Levels in Diabetic Pregnancy
W. URSELL, M. BRUDENELL, T. CHARD British Medical journal, 1973, 2, 80-82 Summary A prospective study has been carried out of placental lactogen levels in pregnancy complicated by diabetes mellitus. The levels were higher than those in normal pregnant subjects; the higher levels were related to increased placental and fetal weight but more closely to the former; and lower levels were found when there was clinical evidence of placental dysfunction. Those patients requiring the largest insulin increment for the control of their diabetes in the pregnancy have placental lactogen levels in the higher range.
Introduction
The chemical 4nd biological similarity between human placental lactogen (HPL) and human growth hormone suggests that it plays a part in the altered carbohydrate metabolism of pregnancy (Grumbach at al.,-1966; Beck and Daughaday, 1967; Samaan et al., 1968; Kalkhoff, 1969) . It may also be a useful diagnostic marker for fetal well-being in pregnanoes complicated by diabetes mellitus (see table) . The present study, which is based ona large number of samples from 34 consecutive pregnant diabetic patients, was designed to assess the relation of HPL levels to insulin requirements during pregnancy, and to define further its place as an index of fetal risk in diabetic pregnancies. Brudenell and Beard, 1972. Infant weight at delivery was expressed as a percentile above or below the normal mean corrected for gestational age, sex, and parity, and placental weight as the number of grammes above or below the normal mean after correction for gestational age.
Insulin increment was calculated as the percentage increase in the dose at delivery over that required at 20 weeks. Thirteen patients had increments above 100% and 13 patients increments below 100%.
A group of 11 patients with evidence of placental dysfunction in addition to diabetes was distinguished. This included four cases of pre-eclamptic toxaemia, seven with infants whose birth weight was below the 25th percentile for their period of gestation, and three in which fetal distress, confirmed by cardiotochometry and pH estimations, occurred in labour.
Blood samples were coUlected at each antenatal visit from 20 weeks' gestation onwards, and weekly during routine admission from 32 weeks until delivery. Specimens were collected between 11 a.m. and noon, and plasma HPL levels measured using a semiautomated radioimmunoassay (Letchworth et al., 1971) . All results were analysed after logarithmic transformation, and the significance of differences between means assessed by Student's t test.
Results
For the whole group mean HPL levels were above those of the normal population after the 28th week ( fig. 1 ). The levels were related to both placental and fetal weight (P < 0001 and < 0 05). The levels were lower in those subjects with placental dysfunction than those without (P < 0 001) ( fig. 2) group 63% of levels were below 5 ,ug/ml after the 34th week, in contrast to 21% in patients without evidence of placental dysfunction. Higher levels were found in patients with an insulin increment greater than 100% than in those where the increment was less than 100% (P < 0 005) ( fig. 3 ).
of the condition, and which is further confirmed by the clear-cut relation between HPL levels and placental weight. The finding of a significant but less striking relation to fetal weight is likely to be a secondary association. The levels of HPL are reduced in the cases of diabetic pregnancy in which the fetus is at greatest risk. Interpretation of these levels, however, depends on a knowledge of the range of levels associated with the complication, as previously found with pre-eclampsia (Letchworth and Chard, 1972a) . Levels are higher than those in a normal pregnancy, and a level which is apparently "normal" may, in a diabetic, be low, and thus of prognostic significance. As an arbitrary limit, 5 lAg/ml provides a clinically useful division for the separation of diabetic pregnancies into those with and those without placental dysfunction. However, there is considerable overlap between these groups and it may be expected that the results of serial values will be of still greater value (Letchworth and Chard, 1972b) . Full evaluation of this possibility will require the accumulation of further data.
The observation that insulin requirements are related to HPL levels is compatible with the known diabetogenic effect of this hormone. The relation is probably direct, but other factorsnotably, the placental steroids (Kalkhoff et al., 1970; Costrini and Kalkhoff, 1971 )-may also be involved in the altered carbohydrate metabolism of pregnancy.
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Introduction
Cutaneous vasculitis refers to a miscellaneous group of conditions in which one of the primary histological defects is inflammation of the skin blood vessels; fibrinoid necrosis and vasular occlusion may follow. The clinical picture depends on the site, size, and number of vessels affected, and so one may see any combination of purpura, papules, nodules, necrosis, and even ulceration. The pathogenesis, however, is unknown but recent investigations (Cochrane, 1968; Katz et al., 1968; Cream, 1972) (Isacson et al., 1970) and appear at the moment to be of little help in the understanding of the development of the vasculitic lesion. Studies of fibrinolysis, however, have been more detailed and interesting. Cunliffe (1968) reported three patients who had a persistently reduced fibrinolytic activity as shown by a prolonged euglobulin lysis time, and which retumed to normal in two cases as the vasculitis spontaneously healed.
Cunliffe and Menon (1971) further investigated 52 patients with a vasculitis predominantly affecting the skin. Of these, 32 patients had a significantly reduced plasma fibrinolytic activity. The same authors reported in an uncontrolled study that in nine out of 10 patients who received oral fibrinolytic therapy with phenformin hydrochloride and ethyloestrenol clinical improvement occurred over a period of 6-36 weeks. Isacson et al., (1970) reported a decreased blood fibrinolytic activity in four of 11 patients with chronic vasculitic lesions of the lower legs. Parish (1972) also reported eight patients six of whom had a decreased blood fibrinolytic activity. In contrast to these findings, however, Kurban and Ryan (1969) and Vaithianathan and Takats (1968) were unable to detect a reduced fibrinolytic activity in patients with a vasculitis.
Published data on the treatment of cutaneous vasculitis with fibrinolytic therapy from other centres are not available. Clearly, therefore, the field was set for a more detailed, preferably double-blind study of oral fibrinolytic therapy in patients with chronic vasculitis. At the same time it appeared prudent to measure fibrinogen-fibrin-related antigen (F.R.-antigen) in these patients with a demonstrable disorder of their fibrinolytic mechanisms.
Patients and Methods Each of the 13 patients who entered the trial had a vasculitis of at least six months' duration and the clinical details are
